AVE Science & Technology Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 24.13%

AVE Science & Technology Co Ltd (688067) has an Asset Resilience Ratio of 24.13% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 688067 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.

Liquid Assets

CN¥147.54 Million
≈ $21.59 Million USD Cash + Short-term Investments

Total Assets

CN¥611.46 Million
≈ $89.48 Million USD All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio Trend (2020–2024)

This chart shows how AVE Science & Technology Co Ltd's Asset Resilience Ratio has changed over time. See AVE Science & Technology Co Ltd balance sheet quality to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down AVE Science & Technology Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 688067 stock market capitalisation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥147.54 Million 24.13%
Total Liquid Assets CN¥147.54 Million 24.13%

Asset Resilience Insights

  • Good Liquidity Position: AVE Science & Technology Co Ltd maintains a healthy 24.13% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company has significant short-term investments, indicating active treasury management.

AVE Science & Technology Co Ltd Industry Peers by Asset Resilience Ratio

Compare AVE Science & Technology Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Tecan Group AG
SW:TECN
Medical Instruments & Supplies 20.48%
Nanosonics Ltd
AU:NAN
Medical Instruments & Supplies 46.84%
SWS Hemodialysis Care Co. Ltd. A
SHG:688410
Medical Instruments & Supplies 38.45%
Formosa Optical Technology Co Ltd
TWO:5312
Medical Instruments & Supplies 46.32%
ZEN Graphene Solutions Ltd
V:ZEN
Medical Instruments & Supplies 4.79%
GETS Global Bhd
KLSE:5079
Medical Instruments & Supplies 0.03%
Ansell Ltd
AU:ANN
Medical Instruments & Supplies 7.53%
SDI Ltd
AU:SDI
Medical Instruments & Supplies 3.36%

Annual Asset Resilience Ratio for AVE Science & Technology Co Ltd (2020–2024)

The table below shows the annual Asset Resilience Ratio data for AVE Science & Technology Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 3.18% CN¥17.86 Million
≈ $2.61 Million
CN¥561.00 Million
≈ $82.09 Million
+2.28pp
2023-12-31 0.90% CN¥5.01 Million
≈ $732.63K
CN¥556.69 Million
≈ $81.46 Million
-22.31pp
2022-12-31 23.21% CN¥127.59 Million
≈ $18.67 Million
CN¥549.65 Million
≈ $80.43 Million
+11.34pp
2021-12-31 11.87% CN¥65.00 Million
≈ $9.51 Million
CN¥547.61 Million
≈ $80.13 Million
+0.07pp
2020-12-31 11.80% CN¥35.00 Million
≈ $5.12 Million
CN¥296.57 Million
≈ $43.40 Million
--
pp = percentage points

About AVE Science & Technology Co Ltd

SHG:688067 China Medical Instruments & Supplies
Market Cap
$214.83 Million
CN¥1.47 Billion CNY
Market Cap Rank
#16353 Global
#4628 in China
Share Price
CN¥21.59
Change (1 day)
+0.75%
52-Week Range
CN¥20.59 - CN¥29.63
All Time High
CN¥37.29
About

AVE Science&Technology CO.,LTD researches, develops, manufactures, markets, and services medical devices, biological reagents, remote medical diagnosis network, computer software, automatic control devices, and medical auxiliary equipment China, Europe, the United States, Asia, Africa, and internationally. The company offers urine formed elements analyzer and related reagents, automatic urine ana… Read more